US Patent 7595395 Gabaergic agents to treat memory deficits
Patent 7595395 was granted and assigned to Wisys Technology Foundation on September, 2009 by the United States Patent and Trademark Office.
All edits
Edits on 16 Sep, 2023
Golden AI
Edits made to:
Article (+319 characters)
Article
Patent abstract
The present invention provides molecules and methods for the prevention and/or treatment of memory deficit related conditions and/or enhancement of cognizance. In a preferred embodiment, the invention includes compounds, salts and prodrugs thereof for the prevention and/or treatment of these conditions.
Edits on 22 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 13 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07595395 Gabaergic agents to treat memory deficits US Patent 7595395 Gabaergic agents to treat memory deficits
Infobox
Patent Number
0759539500
Patent Number
759539500
Edits on 7 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
075953950
Date of Patent
September 29, 2009
0Patent Application Number
113836240
Date Filed
May 16, 2006
0Official Website
Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
075953950
Date of Patent
September 29, 2009
0Patent Application Number
113836240
Date Filed
May 16, 2006
0Official Website
Patent Primary Examiner
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 3 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07595395 Gabaergic agents to treat memory deficits
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07595395
Date of patent
September 29, 2009
Patent application number
11383624
Date Filed
May 16, 2006
Patent primary examiner
Find more entities like US Patent 7595395 Gabaergic agents to treat memory deficits
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.